Bacteriophages: A Challenge for Antimicrobial Therapy.

Area of Science:

• Microbiology
• Virology
• Infectious Diseases

Background:

• The rise of multidrug-resistant (MDR) bacteria presents a critical global health challenge.
• Bacteriophages (phages), viruses that infect bacteria, are being re-evaluated as a therapeutic strategy.
• Traditional antibiotics face limitations against MDR bacterial strains.

Purpose of the Study:

• To review the historical context and recent advancements in phage therapy research.
• To explore the genomics, host interactions, and applications of phages.
• To discuss the mechanisms of action and therapeutic potential of phages against MDR infections.

Main Methods:

• Literature review of historical and current research on bacteriophages.
• Analysis of genomic data and host-bacterial interactions.
• Examination of medical and biotechnological applications of phage therapy.

Main Results:

• Phage therapy shows promise as an alternative to antibiotics for MDR bacterial infections.
• Understanding phage genomics and host interactions is key to optimizing therapeutic use.
• Phages have diverse mechanisms of action against bacteria, including lysis.

Conclusions:

• Phage therapy is a viable and evolving strategy to combat MDR bacterial infections.
• Further research into phage mechanisms and applications is crucial for clinical translation.
• Phage therapy holds significant potential in addressing infections involving complex virus-bacteria interactions.